: +31 (0) 317 453 908
: info@check-points.com

Distributors

Select your local distributor:

Check-ESBL

Control ESBL

ESBLCTX-M, TEM and SHV

The Need

  • The prevalence of ESBL is growing at an alarming rate.
  • Phenotypic methods in use today overstate the ESBL problem, leading to costly unnecessary patient isolation and inappropriate treatment.
  • For non-E. coli and non-Klebsiella these methods often fail to identify ESBL.

The Solution: Check-ESBL

  • A molecular assay.
  • Simultaneous identification of the clinically prevalent ESBL genes.
  • High sensitivity and specificity for all species.
  • Results can be obtained within 6 hours.
  • Includes software for instant automated analysis of results.

For research use only in the US.


newsletter

Thank you for your interest!

The Check-Points newsletter helps you to stay updated on the the latest developments in gram negative antibiotic resistance.

Sent on a quarterly basis, the newsletter features the latest news from Check-Points as well as summaries of key publications in the field and links to relevant news stories. Special issues will appear for ICAAC and ECCMID.

Subscribe below: